DnaJC7 specifically regulates tau seeding
Abstract
Neurodegenerative tauopathies are caused by accumulation of toxic tau protein assemblies. This appears to involve template-based seeding events, whereby tau monomer changes conformation and is recruited to a growing aggregate. Several large families of chaperone proteins, including Hsp70s and J domain proteins (JDPs) cooperate to regulate the folding of intracellular proteins such as tau, but the factors that coordinate this activity are not well known. The JDP DnaJC7 binds tau and reduces its intracellular aggregation. However, it is unknown whether this is specific to DnaJC7 or if other JDPs might be similarly involved. We used proteomics within a cell model to determine that DnaJC7 co-purified with insoluble tau and colocalized with intracellular aggregates. We individually knocked out every possible JDP and tested the effect on intracellular aggregation and seeding. DnaJC7 knockout decreased aggregate clearance and increased intracellular tau seeding. This depended on the ability of the J domain (JD) of DnaJC7 to stimulate Hsp70 ATPase activity, as JD mutations that block this interaction abrogated the protective activity. Disease-associated mutations in the JD and substrate binding site of DnaJC7 also abolished its protective activity. DnaJC7 thus specifically regulates tau aggregation in cooperation with Hsp70.
Data availability
All data generated or analyzed during this study are included in the manuscript and supporting file. Source Data files for included Western Blot images are provided as Figure 1 - Supplement 1 - Source Data 1, Figure 2 - Supplement 1 - Source Data 1, Figure 3 -Supplement 1 - Source Data 1, and Figure 5 - Supplement 1 - Source Data 1. Source data files have been provided for Figures 1 (Source Data 1 and 2) and 2 (Source Data 3) on Dryad at: https://doi.org/10.5061/dryad.fj6q57402FCS files are deposited on Cytobank at: https://community.cytobank.org/cytobank/projects/1505
-
DnaJC7 specifically regulates tau seedingDryad Digital Repository, doi:10.5061/dryad.fj6q57402.
Article and author information
Author details
Funding
National Institute on Aging (RF1AG078888)
- Valerie Ann Perez
- Vishruth Mullapudi
- Lukasz A Joachimiak
National Institute on Aging (3R01AG048678)
- Valerie Ann Perez
- David W Sanders
- Ayde Mendoza-Oliva
- Barbara Elena Stopschinski
- Marc I Diamond
National Institute on Aging (1RF1AG059689)
- Valerie Ann Perez
- David W Sanders
- Ayde Mendoza-Oliva
- Barbara Elena Stopschinski
- Charles L White III
- Marc I Diamond
National Institute on Aging (1RF1AG065407)
- Valerie Ann Perez
- David W Sanders
- Ayde Mendoza-Oliva
- Barbara Elena Stopschinski
- Vishruth Mullapudi
- Lukasz A Joachimiak
- Marc I Diamond
McCune Foundation
- Charles L White III
Winspear Family Center for Research on the Neuropathology of Alzheimer's Disease
- Charles L White III
Chan Zuckerberg Initiative (2018-191983)
- Charles L White III
- Lukasz A Joachimiak
- Marc I Diamond
Chan Zuckerberg Initiative (2021-237348)
- Charles L White III
- Lukasz A Joachimiak
- Marc I Diamond
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2023, Perez et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,068
- views
-
- 172
- downloads
-
- 7
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Chromosomes and Gene Expression
The mRNA 5'-cap structure removal by the decapping enzyme DCP2 is a critical step in gene regulation. While DCP2 is the catalytic subunit in the decapping complex, its activity is strongly enhanced by multiple factors, particularly DCP1, which is the major activator in yeast. However, the precise role of DCP1 in metazoans has yet to be fully elucidated. Moreover, in humans, the specific biological functions of the two DCP1 paralogs, DCP1a and DCP1b, remain largely unknown. To investigate the role of human DCP1, we generated cell lines that were deficient in DCP1a, DCP1b, or both to evaluate the importance of DCP1 in the decapping machinery. Our results highlight the importance of human DCP1 in decapping process and show that the EVH1 domain of DCP1 enhances the mRNA-binding affinity of DCP2. Transcriptome and metabolome analyses outline the distinct functions of DCP1a and DCP1b in human cells, regulating specific endogenous mRNA targets and biological processes. Overall, our findings provide insights into the molecular mechanism of human DCP1 in mRNA decapping and shed light on the distinct functions of its paralogs.
-
- Biochemistry and Chemical Biology
- Cell Biology
Myosin 10 (Myo10) is a motor protein known for its role in filopodia formation. Although Myo10-driven filopodial dynamics have been characterized, there is no information about the absolute number of Myo10 molecules during the filopodial lifecycle. To better understand molecular stoichiometries and packing restraints in filopodia, we measured Myo10 abundance in these structures. We combined SDS-PAGE densitometry with epifluorescence microscopy to quantitate HaloTag-labeled Myo10 in U2OS cells. About 6% of total intracellular Myo10 localizes to filopodia, where it enriches at opposite cellular ends. Hundreds of Myo10s are in a typical filopodium, and their distribution across filopodia is log-normal. Some filopodial tips even contain more Myo10 than accessible binding sites on the actin filament bundle. Live-cell movies reveal a dense cluster of over a hundred Myo10 molecules that initiates filopodial elongation. Hundreds of Myo10 molecules continue to accumulate during filopodial growth, but accumulation ceases when retraction begins. Rates of filopodial elongation, second-phase elongation, and retraction are inversely related to Myo10 quantities. Our estimates of Myo10 molecules in filopodia provide insight into the physics of packing Myo10, its cargo, and other filopodia-associated proteins in narrow membrane compartments. Our protocol provides a framework for future work analyzing Myo10 abundance and distribution upon perturbation.